Feeds
813 results total, viewing 1 - 20
Nourish’s Series B round was led by J.P. Morgan Private Capital’s Growth Equity Partners. In total, the company has raised $115 million. The post Nourish Lands $70M to Fight Chronic Disease … more
Contraline released promising new trial data showing that its male contraceptive gel has demonstrated safety and efficacy in the first two trial participants to reach the two-year mark. The company … more
A government-commissioned report in the UK has found that efforts to crack down on drug activity through law enforcement are more likely to drive up violence rather than decrease it. While it’s … more
Massimo Group (NASDAQ: MAMO), a manufacturer of powersports vehicles, is reinforcing its market position through strategic retail partnerships and a commitment to quality and innovation. By … more
When Congress returns next week, it will be writing a budget reconciliation bill that’s expected to cut taxes but also make deep cuts to Medicaid. But at least some Republicans are concerned about … more
Etiome’s precision medicine approach introduces a temporal component to treating disease — drugs developed specifically to treat disease at particular points in time even before symptoms show. … more
Thumzup (NASDAQ: TZUP) is shaking up the multibillion-dollar marketing industry with the launch of its patent-pending Lifestyle AI Agent Marketplace. The company’s new AI application, Gibberlink … more
The health insurer unintentionally exposed the personal data of 4.7 million people to Google through a misconfigured analytics tool used between 2021 and 2024. more
InnerScope (OTC: INND) today announced the official grand opening of OTCHealthMart.com, a cutting-edge online platform designed to make healthcare products accessible and affordable for everyone. … more
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced the completion of physical assembly for its Advantage2TM annealing quantum system at Davidson Technologies’ headquarters in Huntsville, … more
Watch the Video Here The post KTLA Cares Segment- April 2025 appeared first on All For Kids. more
Continue reading at Credihealth Blog » more
ADHD has been considered a medical disorder, treatable with drugs like Ritalin, but New York Times Magazine writer Paul Tough says recent studies question that assumption and treatment options. more
Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of … more
ESGold (CSE: ESAU) (OTCQB: ESAUF) has identified a large-scale, high-conductivity geophysical anomaly in the southwestern portion of its Montauban Project following an internal review of its 2015 … more
Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) doing business as MedCana, announced the cancellation of 16,193,760 shares and the swap of 72,750,081 common shares for preferred stock, … more
House Rep. Gerry Connolly is pushing CDC leadership to explain why the personnel who handle FOIA requests lost their jobs, noting that that the public has a right to access federal records. more
Knightscope (NASDAQ: KSCP) a developer of autonomous security robots and AI technologies, announced over $1.2 million in new contracts, including major renewals and expansions across the U.S. The … more
ROMEO stands for "retired older men eating out," and it's helping guys in one Maine town get out of the house and into more friendships. more
Disseminated on behalf of SolarBank Corporation Zacks Small-Cap Research has launched coverage of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and … more
1 | 2 | 3 | 4 | 5 | 6 | 7 41 | Next »